MECHANICAL CIRCULATORY SUPPORT - ADULT (MCS) -> MCS - Therapeutics and Pharmacology Abstracts

304 - The Effect of Renin-Angiotensin-Aldosterone System Inhibition on Morbidity and Mortality during Long-Term Continuous-Flow Left Ventricular Assist Device Support

Presentation Number
304
Speakers
Session Name
SESSION 77 - ORAL: Optimal Drug Therapy and Monitoring of MCS Patients
Date
Sat, Apr 25, 2020
Time
12:30 PM - 02:15 PM
Authors

Previous ePresentation
303 - Association between Angiotensin II Antagonism and Mortality after LVAD Implantation: A Multi-Center, Contemporary Analysis

Next ePresentations
306 - Partial Recovery of Ejection Fraction with Neurohormonal Blockade Improves Long-Term Event Free Survival for Patients with Continuous Flow LVAD
307 - The Depolarization Amplitude of the Electromyogram is a Measure of End-Diastolic Ventricular Volume
308 - Feasibility and Patient Perceptions of Tele-Videoconferencing Visits for LVAD Patients (TeleLVAD Study)
311 - Ischemia and Reperfusion Injury in Donation after Circulatory Death Heart: Role of Interleukin-1
316 - Utilization of New Heart Preservation Technology in the Era of New Organ Allocation and Extended Ischemic Times
319 - Indications for LVAD Explant and Predictors of Mortality after Explant in IMACS
322 - Predicting Cardiac Structural and Functional Improvement Induced by Mechanical Unloading in Chronic Heart Failure: A Derivation-Validation Multicenter Study
324 - Lung Transplantation and Utilisation Following Donation after Circulatory Death (DCD) in the UK
329 - Calculating the Lung Allocation Score Error for ECMO Patients
330 - Effect of Donor Death by Drug Intoxication Combined with Chronic Drug Abuse on Lung Transplantation: A Single Center Study